COX-2-IN-6
CAS No. 2756347-91-6
COX-2-IN-6( —— )
Catalog No. M35615 CAS No. 2756347-91-6
COX-2-IN-6 is a potent, selective, and orally available cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 0.84 μM and a Ki of 69 nM.COX-2-IN-6 inhibits COX-2-driven PGE2 synthesis with an IC50 of 0.60 μM.COX-2-IN-6 is used to prevent colorectal cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 102 | Get Quote |
|
| 5MG | 155 | Get Quote |
|
| 10MG | 235 | Get Quote |
|
| 25MG | 410 | Get Quote |
|
| 50MG | 593 | Get Quote |
|
| 100MG | 858 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCOX-2-IN-6
-
NoteResearch use only, not for human use.
-
Brief DescriptionCOX-2-IN-6 is a potent, selective, and orally available cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 0.84 μM and a Ki of 69 nM.COX-2-IN-6 inhibits COX-2-driven PGE2 synthesis with an IC50 of 0.60 μM.COX-2-IN-6 is used to prevent colorectal cancer.
-
DescriptionCOX-2-IN-6 (compound 10) is an orally active, gut-restricted and selective cyclooxygenase-2 (COX-2) inhibitor for colorectal Chemoprevention of cancer. COX-2-IN-6 selectively targets COX-2 with an IC50 of 0.84 μM and a Ki of 69 nM. COX-2-IN-6 also inhibits COX-2-driven PGE2 synthesis with an IC50 of 0.60 μM.
-
In Vitro——
-
In VivoAnimal Model:APCmin/+ mouse model Dosage:30 mg/kg, 100 mg/kg, 300 mg/kg Administration:PO; daily in chow diet Result:Significantly decreased [18F]-FDG uptake and polyp area.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX | Prostaglandin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2756347-91-6
-
Formula Weight409.5
-
Molecular FormulaC20H27NO6S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (244.20 mM; Ultrasonic )
-
SMILESO(CC(C)(C)O)C1=C(C=C(CO)C(OCCC)=N1)C2=CC=C(S(C)(=O)=O)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang Z, et al. Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer. J Med Chem. 2021 Aug 12;64(15):11570-11596. ?
molnova catalog
related products
-
Mefenamic acid
Mefenamic acid is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of mefenamic acid is as a Cyclooxygenase Inhibitor.
-
Nepodin
Nepodin has antimalarial, and anti-inflammatory activities, it shows significant cyclooxygenase (COX) inhibitory activity.
-
ATB 346
ATB-346 is a novel hydrogen sulphide-releasing derivative of naproxen with markedly reduced toxicity.
Cart
sales@molnova.com